Collaborative initiatives and novel AI tools are helping to advance lung cancer screening, but participation barriers and disparities persist despite guideline expansions.
Key Details
- 1Lung cancer screening uptake with low-dose CT (LDCT) increased from 4.5% in 2023 to 16% in 2024, with state variation from 9.7% to 35.5%.
- 2AI deep-learning tools (e.g., from Radboud) have reduced false-positive nodule results by nearly 40%.
- 3Barriers to high screening rates include insurance preauthorization, patient knowledge, provider communication, and logistical factors.
- 4The ACR Lung Cancer Screening Registry (LCSR) is evolving into the Early Lung Cancer Detection Registry (ELCDR) to improve tracking and follow-up of both screening and incidental nodules.
- 5Guideline updates expanded eligibility, but disparities in demographic participation remain and nodule overdiagnosis is a concern.
- 6RSNA 2025 and other conferences will feature major sessions on personalized AI risk tools and screening strategies.
Why It Matters

Source
AuntMinnie
Related News

AI Improves Chest CT Workflow and Reduces Radiation Without Compromising Quality
AI-driven automatic positioning in chest CT reduces radiation dose and improves workflow efficiency without affecting image quality.

AI Advances Push Opportunistic Imaging Into Clinical Focus
AI-powered opportunistic screening is transforming routine radiological images into proactive tools for risk detection of major diseases.

Multi-Institution Study Validates LLMs for Annotating Radiology Reports
A multi-center study shows LLMs, with optimized prompts, provide consistent and scalable annotation of radiology reports across six major U.S. institutions.